Clinical Trial Update: Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of Lucentis (ranibizumab) for diabetic macular edema has completed. The update is reported by Rocky Mountain Retina Consultants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Rocky Mountain Retina Consultants | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Phase 2 | Status: COMPLETED